胶质母细胞瘤干细胞中替莫唑胺耐药性的差异性演化反映于细胞外囊泡并与放射增敏相耦合
本研究在具有原神经(PN)或间充质(MES)分子特征的人胶质瘤干细胞(GSC)异种移植模型中探索替莫唑胺(TMZ)耐药性的分子与细胞演化。结果显示,同一同基因GSC系来源的肿瘤表达分歧且复杂的TMZ耐药标志谱,仅少数伴O6-甲基鸟嘌呤DNA甲基转移酶(MGMT)上调;部分MES GSC来源的TMZ耐药肿瘤中间充质特征持续减少,与Nestin表达增加、转谷氨酰胺酶2下降及放射敏感性相关。GSC释放的细胞外囊泡(EVs)转录组可重现TMZ耐药与干细胞表型的mRNA表达谱。作者认为,利用治疗诱导的GSC表型变化及交替治疗周期可能改善GBM结局。
要点
- 同一同基因GSC系来源的颅内异种移植瘤对TMZ的初始反应最终被难治性生长模式取代。
- TMZ耐药标志谱呈分歧且复杂表达,仅少数伴MGMT上调。
- 部分MES GSC来源的TMZ耐药肿瘤中间充质特征持续减少,与Nestin升高、转谷氨酰胺酶2下降及放射敏感性相关。
核心结论
- 肿瘤起始细胞区室的内在变化可能包括亚型特征丢失及化疗与放疗敏感性的相应改变。
- 作者认为,利用治疗诱导的GSC表型变化及交替治疗周期可能改善GBM结局。
研究设计与样本
- 在具有原神经(PN)或间充质(MES)分子特征的一系列人GSC中,于体内(异种移植模型)探索TMZ耐药性的分子与细胞演化。
主要发现
- GSC引发的颅内异种移植瘤对TMZ的初始反应最终被难治性生长模式取代。
- 同一同基因GSC系来源的个体肿瘤表达分歧且复杂的TMZ耐药标志谱,仅少数伴MGMT上调。
- 在若干MES GSC来源的独立TMZ耐药肿瘤中,间充质特征持续减少,该变化在细胞培养中持续存在,并与Nestin表达增加、转谷氨酰胺酶2下降及放射敏感性相关。
- 反映TMZ耐药与干细胞表型的相应mRNA表达谱可在GSC释放至培养基的类外泌体细胞外囊泡(EVs)转录组中重现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioblastoma (GBM) is almost invariably fatal due to failure of standard therapy. The relapse of GBM following surgery, radiation, and systemic temozolomide (TMZ) is attributed to the ability of glioma stem cells (GSCs) to survive, evolve, and repopulate the tumor mass, events on which therapy exerts a poorly understood influence. METHODS: Here we explore the molecular and cellular evolution of TMZ resistance as it emerges in vivo (xenograft models) in a series of human GSCs with either proneural (PN) or mesenchymal (MES) molecular characteristics. RESULTS: We observed that the initial response of GSC-initiated intracranial xenografts to TMZ is eventually replaced by refractory growth pattern. Individual tumors derived from the same isogenic GSC line expressed divergent and complex profiles of TMZ resistance markers, with a minor representation of O6-methylguanine DNA methyltransferase (MGMT) upregulation. In several independent TMZ-resistant tumors originating from MES GSCs we observed a consistent diminution of mesenchymal features, which persisted in cell culture and correlated with increased expression of Nestin, decline in transglutaminase 2 and sensitivity to radiation. The corresponding mRNA expression profiles reflective of TMZ resistance and stem cell phenotype were recapitulated in the transcriptome of exosome-like extracellular vesicles (EVs) released by GSCs into the culture medium. CONCLUSIONS: Intrinsic changes in the tumor-initiating cell compartment may include loss of subtype characteristics and reciprocal alterations in sensitivity to chemo- and radiation therapy. These observations suggest that exploiting therapy-induced changes in the GSC phenotype and alternating cycles of therapy may be explored to improve GBM outcomes.
引用
- Garnier D, Meehan B, Kislinger T, et al. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization. Neuro Oncol. 2018. PMID: 29016925. doi:10.1093/neuonc/nox142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。